Bio-Techne (TECH) Inventory Average (2010 - 2026)
Bio-Techne's (TECH) quarterly Inventory Average came in at $203.3 million in Q1 2026, up 7.16% year-on-year from $189.7 million in Q1 2025, and little changed quarter-over-quarter from $204.3 million in Q4 2025.
Bio-Techne (TECH) Inventory Average (2010 - 2026) Analysis & Trends
Bio-Techne's Inventory Average history runs 17 years deep, the most recent figure standing at $203.3 million for Q1 2026.
- On a quarterly basis, Inventory Average rose 7.16% year-over-year to $203.3 million in Q1 2026; TTM through Mar 2026 was $203.3 million, a 7.16% increase from a year earlier, with the FY2025 full-year figure at $184.6 million, up 5.07% from the prior year.
- Inventory Average held at $203.3 million in Q1 2026 per TECH's latest filing, from $204.3 million in the prior quarter.
- Across five years, Inventory Average topped out at $204.3 million in Q4 2025 and bottomed at $125.1 million in Q1 2022.
- The 5-year median for Inventory Average is $180.2 million (2024), against an average of $174.8 million.
- Across the five-year window, Inventory Average surged 31.8% in 2023 and climbed 1.77% in 2024, its largest moves.
- Year by year, Inventory Average stood at $155.1 million in 2022, then rose by 18.27% to $183.5 million in 2023, then gained by 1.77% to $186.7 million in 2024, then climbed by 9.43% to $204.3 million in 2025, then retreated by 0.49% to $203.3 million in 2026.
- Per Business Quant, the three latest TECH Inventory Average figures stand at $203.3 million (Q1 2026), $204.3 million (Q4 2025), and $196.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 644.91 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.15 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Bio-Techne | 11.23 Bn | 11.02 Bn | 208.29 Mn | 203.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 203.31 Mn |
| Dec 31, 2025 | 204.32 Mn |
| Sep 30, 2025 | 196.32 Mn |
| Jun 30, 2025 | 190.26 Mn |
| Mar 31, 2025 | 189.73 Mn |
| Dec 31, 2024 | 186.71 Mn |
| Sep 30, 2024 | 182.39 Mn |
| Jun 30, 2024 | 179.61 Mn |
| Mar 31, 2024 | 180.17 Mn |
| Dec 31, 2023 | 183.46 Mn |
| Sep 30, 2023 | 178.86 Mn |
| Jun 30, 2023 | 170.55 Mn |
| Mar 31, 2023 | 164.85 Mn |
| Dec 31, 2022 | 155.12 Mn |
| Sep 30, 2022 | 145.57 Mn |
| Jun 30, 2022 | 134.70 Mn |
| Mar 31, 2022 | 125.07 Mn |
| Dec 31, 2021 | 119.61 Mn |
| Sep 30, 2021 | 117.06 Mn |
| Jun 30, 2021 | 113.37 Mn |